China vs Europe (WHO region): Cases started on MDR-TB treatment
China
13,984
in 2024
Europe (WHO region)
40,112
in 2024
China rank
3rd
Europe (WHO region) rank
5th
Cases started on MDR-TB treatment over time
- China
- Europe (WHO region)
How they compare
Europe (WHO region) currently reports 40,112 against 13,984 in China, a difference of 26,128.
That makes Europe (WHO region)'s figure about 2.9 times China's.
Across all 16 years both countries report, Europe (WHO region) has been ahead every year.
China ranks 3rd and Europe (WHO region) ranks 5th of 193 countries.
Europe (WHO region) has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | China | Europe (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 458 | 17,169 | 16,711 | Europe (WHO region) |
| 2010s | 4,884 | 45,082 | 40,198 | Europe (WHO region) |
| 2020s | 12,695 | 45,324 | 32,629 | Europe (WHO region) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cases started on mdr-tb treatment, China or Europe (WHO region)?
- Europe (WHO region), at 40,112 against 13,984 in China as of 2024.
- What is the difference in cases started on mdr-tb treatment between China and Europe (WHO region)?
- 26,128, with Europe (WHO region) ahead.
- How many years of comparable data are there for China and Europe (WHO region)?
- 16 years are reported by both, from 2009 to 2024.
- How do China and Europe (WHO region) rank globally for cases started on mdr-tb treatment?
- China ranks 3rd and Europe (WHO region) ranks 5th of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Cases started on MDR-TB treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.